Skip to content
Menu

Jefferies Upgrades Chemed to Buy, Raises Price Target to $620

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsUpgradesPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $520 to $620.

Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $520 to $620.

Read at benzinga.com

← All stock news